PharmaTher Holdings Ltd. (OTCMKTS:PHRRF – Get Free Report) was the recipient of a significant increase in short interest in the month of September. As of September 15th, there was short interest totaling 35,490 shares, an increase of 98.5% from the August 31st total of 17,878 shares. Based on an average daily volume of 317,265 shares, the days-to-cover ratio is currently 0.1 days.
PharmaTher Price Performance
Shares of OTCMKTS:PHRRF opened at $0.04 on Thursday. PharmaTher has a 52 week low of $0.03 and a 52 week high of $0.29. The company has a 50 day moving average price of $0.04 and a two-hundred day moving average price of $0.04.
About PharmaTher
PharmaTher Inc is a specialty pharmaceutical company focused on developing and commercializing therapies for diseases with significant unmet medical needs. The company’s strategy centers on repurposing established medicines and advancing pharmaceutical products through clinical development and regulatory pathways.
PharmaTher has primarily focused on ketamine-based treatments and psychedelic medicines. Its development programs have included potential applications of ketamine in neurological and psychiatric conditions, including status epilepticus, Parkinson’s disease and related movement disorders.
See Also
- Five stocks we like better than PharmaTher
- Deutsche Bank Makes a Contrarian Call on Netflix—What Does It Mean for Investors?
- O’Reilly Automotive’s Stock Slump Hides a Stronger Business
- McDonald’s Stock Slump Makes Its AI Pricing Bet Even Riskier
- Broadcom’s AI Growth Story Faces a $161 Billion Anthropic Test
Receive News & Ratings for PharmaTher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PharmaTher and related companies with MarketBeat.com's FREE daily email newsletter.
